INNOVATIVE EYEWEAR, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
INNOVATIVE EYEWEAR, INC. (LUCY) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$511.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$569.66K, a 704.35% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $58.14K.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $209.54K, a 221.07% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $267.42K, a 15.56% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $191.52K, a 109.94% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $91.23K, a 69.92% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $303.29K, a 346.34% increase from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $67.95K, a 56.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$569.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$511.51K 10-Q · filed 2026-08-14 | -$301.97K derived: sum of 3 quarters · filed 2026-08-14 | -$34.55K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $58.14K 10-Q · filed 2026-05-14 | $267.69K derived: sum of 2 quarters · filed 2026-05-14 | $535.10K derived: sum of 3 quarters · filed 2026-05-14 | $629.36K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $209.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $476.96K derived: sum of 2 quarters · filed 2026-03-25 | $571.22K derived: sum of 3 quarters · filed 2026-08-14 | $191.52K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $267.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $361.68K derived: sum of 2 quarters · filed 2026-08-14 | -$18.02K 10-Q · filed 2025-11-13 | $47.24K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $94.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$285.44K 10-Q · filed 2026-08-14 | -$220.18K derived: sum of 3 quarters · filed 2026-08-14 | $11.23K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$379.70K 10-Q · filed 2026-05-14 | -$314.44K derived: sum of 2 quarters · filed 2026-05-14 | -$83.03K derived: sum of 3 quarters · filed 2026-05-14 | -$547.48K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $65.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $296.67K derived: sum of 2 quarters · filed 2026-03-25 | -$167.78K derived: sum of 3 quarters · filed 2026-03-25 | $91.23K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $231.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$233.04K derived: sum of 2 quarters · filed 2025-11-13 | $25.96K 10-Q · filed 2025-11-13 | $422.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$464.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$205.44K 10-Q · filed 2025-08-14 | $190.59K derived: sum of 3 quarters · filed 2025-08-14 | $227.56K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $259.01K 10-Q · filed 2025-05-13 | $655.04K derived: sum of 2 quarters · filed 2025-05-13 | $692.01K derived: sum of 3 quarters · filed 2025-05-13 | $547.67K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $396.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $433.00K derived: sum of 2 quarters · filed 2025-03-24 | $288.66K derived: sum of 3 quarters · filed 2025-03-24 | $303.29K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $36.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$107.37K derived: sum of 2 quarters · filed 2024-11-12 | -$92.75K 10-Q · filed 2024-11-12 | -$370.29K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$144.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$129.71K 10-Q · filed 2024-08-12 | -$407.26K derived: sum of 3 quarters · filed 2024-08-12 | -$114.81K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $14.63K 10-Q · filed 2024-05-14 | -$262.92K derived: sum of 2 quarters · filed 2024-05-14 | $29.54K derived: sum of 3 quarters · filed 2024-05-14 | $44.54K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$277.55K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $14.91K derived: sum of 2 quarters · filed 2024-03-25 | $29.91K derived: sum of 3 quarters · filed 2024-03-25 | $67.95K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $292.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $307.46K derived: sum of 2 quarters · filed 2023-11-14 | $345.50K 10-Q · filed 2023-11-14 | $345.50K 10-Q · filed 2022-11-10 | $477.33K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $53.04K 10-Q · filed 2023-08-11 | $184.87K derived: sum of 3 quarters · filed 2023-08-11 | $186.03K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $38.04K 10-Q · filed 2023-05-12 | $169.87K derived: sum of 2 quarters · filed 2023-05-12 | $171.03K derived: sum of 3 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $131.83K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $132.98K derived: sum of 2 quarters · filed 2023-03-24 | $157.54K 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $1.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $25.71K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $24.55K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |